APPLICATION
ANDA073428
TYPE
ANDA
ORIGINAL APPROVAL
1992-01-28
LATEST ACTION
1999-03-23
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued
Products
CO-LAVDiscontinued
POLYETHYLENE GLYCOL 3350 240GM/BOT, POTASSIUM CHLORIDE 2.98GM/BOT, SODIUM BICARBONATE 6.72GM/BOT, SODIUM CHLORIDE 5.84GM/BOT, SODIUM SULFATE ANHYDROUS 22.72GM/BOT · FOR SUSPENSION · ORAL
Approval history
1999-03-23Manufacturing (CMC) · Supplement 2AP
1996-05-31Manufacturing (CMC) · Supplement 1AP
1992-01-28OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.